Flomoxef (FMX) may be a potential alternative to carbapenems for dogs infected with
Enterobacterales-producing extended-spectrum β-lactamase (ESBL-E). However, the …

Purpose Although flomoxef (FMOX) has attracted substantial attention as an antibiotic
against extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-producing E …

The objective of this study was to better understand the in vitro activity of flomoxef against
clinical extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. A total of …

This study compared the efficacy of flomoxef with other β-lactam antibiotics against extended-
spectrum β-lactamases (ESBL)-producing bacteria of clinical relevance. First, the …

To find an alternative regimen for the treatment of extended-spectrum β-lactamase (EBSL)–
producing Enterobacteriaceae infections, we examined the in vitro activity of flomoxef …

This study was carried out to investigate the urinary pharmacokinetics and
pharmacodynamics of faropenem administered orally at 5 mg kg− 1 in six healthy dogs to …

The spread of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) is a
serious concern in companion animal medicine owing to their ability to develop multidrug …

In this age of antimicrobial resistance (AMR), improving treatment using existing antibiotics
is desirable. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales (ESBL …

Objectives: The primary aim of this study was to determine the activities of ceftazidime and
cefepime combined to sulbactam against class A extended-spectrum β lactamases (ESBLs) …

The growing number of infection caused by extended-spectrum/-lactamase (ESBL)
producing pathogens has prompted a more rational use of available antibiotics because of …